The recent instability in global chains have highlighted the value of securing vital medications like Ivermectin. Relying on overseas producers exposes regions to potential vulnerabilities, including shipping delays, cost fluctuations, and even geopolitical threats. Transitioning towards domestic procurement of Ivermectin offers a multitude of bene